on NOVACYT (EPA:ALNOV)
Dr. Ian Gilham Joins Novacyt as Non-Executive Director
Novacyt S.A., an international molecular diagnostics company, has announced the appointment of Dr. Ian Gilham as a Non-Executive Director. His role becomes effective immediately, pending shareholder approval at the upcoming Annual General Meeting.
Dr. Gilham brings extensive experience from various AIM-listed life sciences companies. He's known for his contributions to research, development, and the commercialization of diagnostic products. Currently, he holds executive roles in multiple companies, including Genedrive PLC and LifeArc.
CEO Lyn Rees expressed enthusiasm for Dr. Gilham's appointment, citing his valuable expertise to enhance Novacyt's strategic direction. The decision aligns with Novacyt's commitment to strengthening its board as it optimizes its operations and growth plans.
R. P.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all NOVACYT news